3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
15
Breast Neoplasms
7
Sarcoma
5
Neoplasm Metastasis
4
Carcinoma, Ovarian Epithelial
4
Neoplasms
3
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphadenopathy
1
Interventions
Oxaliplatin
9
Capecitabine
9
pembrolizumab
7
Paclitaxel
7
Fluorouracil
7
Leucovorin
6
Cisplatin
6
zolbetuximab
5
Gemcitabine
4
trastuzumab deruxtecan
3
enzalutamide
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Pemetrexed
3
Docetaxel
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
darolutamide
2
Taxes
2
Ramucirumab
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Nivolumab
2
Irinotecan
2
Cyclophosphamide
2
Androgen Antagonists
2
Albumin-Bound Paclitaxel
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
liposomal doxorubicin
×
90 days
×
Clear all
No trials found.